Table 1.

The characteristics of the selected papers

Author, yr (Ref)	Country	Design	Sample size	Mean age of women (yr)	Cancer type	FSD prevalence (%)
Reese et al. , 2018 (26)	USA	Prospective	59	- Colorectal	58
Moroney et al. , 2018 (35)	USA	Cross-sectional	91	54.4 $\pm$ 12.3	Multiple	38
Moroney et al. , 2018 (35)	USA	Cross-sectional	60	54.0 $\pm$ 12.2	Multiple	47
Faten et al. , 2018 (15)	Tunisia	Cross-sectional	100	42.6 $\pm$ 6.9	Breast	75
Chan et al. , 2018 (33)	USA	Cross-sectional	529	- Ovary-Uterus	77.3
Robinson et al. , 2017 (16)	Canada	Prospective	625	- Breast	85.7
He et al. , 2017 (27)	China	Retrospective	1071	- Cervical	47
He et al. , 2017 (27)	China	Retrospective	792	- Cervical	58.6
Gass et al. , 2017 (17)	USA	Cross-sectional	186	58.7	Breast	42
Paiva et al. , 2016 (18)	Brazil	Cross-sectional	153	51.9 $\pm$ 9.2	Breast	63
Boquiren et al. , 2015 (19)	Canada	Cross-sectional	127	49.0 $\pm$ 7.9	Breast	82.5
Carter et al. , 2015 (36)	USA	Cross-sectional	190	51.8 $\pm$ 10.4	Multiple	93.5
Damast et al. , 2014 (30)	USA	Cross-sectional	205	- Endometrial	80
Raggio et al. , 2014 (20)	USA	Cross-sectional	83	56.2	Breast	76.5
Schover et al. , 2014 (21)	USA	Cross-sectional	129	63.9	Breast	92
Safarinejad et al. , 2013 (22)	Iran	Cross-sectional	186	37.7	Breast	52.5
Segelman et al. , 2013 (34)	Sweden	Cross-sectional	82	- Rectum	52.4
Damast et al. , 2012 (31)	USA	Cross-sectional	104	- Endometrial	81
Pumo et al. , 2012 (23)	Italy	Cross-sectional	162	- Breast	34.7
Onujiogu et al. , 2011 (32)	USA	Cross-sectional	72	59.5	Endometrial	89
Tsai et al. , 2011 (28)	Taiwan	Cross-sectional	105	54.3	Cervical	66.6
Harirchi et al. , 2012 (24)	Iran	Prospective	216	44.3	Breast	84
Author, yr (Ref)	Country	Design	Sample size	Mean age of women (yr)	Cancer type	FSD prevalence (%)
Carter et al. , 2010 (29)	USA	Prospective	71	34.5	Cervical	55
Boehmer et al. , 2014 (25)	USA	Case-control	85	51.6	Breast	52.5
FSD: Female sexual dysfunction